Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sarobe

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Cancer Research|December 17, 2010
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppressionNancy Díaz-Valdés, María Basagoiti, Javier Dotor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Oncotarget|December 8, 2016
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccinationDiana Llopiz, Marta Ruiz, Stefany Infante, et al.
Oncoimmunology|February 6, 2014
Helper cell-independent antitumor activity of potent CD8<sup>+</sup> T cell epitope peptide vaccines is dependent upon CD40LDiana Llopiz, Eduardo Huarte, Marta Ruiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2007
Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 proteinAintzane Zabaleta, Diana Llopiz, Laura Arribillaga, et al.
Cancers|July 2, 2021
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationNoelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Journal of Virology|April 23, 2002
Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteinsPablo Sarobe, Juan José Lasarte, Noelia Casares, et al.
Cytokine|December 28, 2010
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisLaura Arribillaga, Javier Dotor, María Basagoiti, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Cancer Research|December 17, 2010
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppressionNancy Díaz-Valdés, María Basagoiti, Javier Dotor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacementsEduardo Huarte, Pablo Sarobe, Jun Lu, et al.
Oncotarget|December 8, 2016
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccinationDiana Llopiz, Marta Ruiz, Stefany Infante, et al.
Oncoimmunology|February 6, 2014
Helper cell-independent antitumor activity of potent CD8<sup>+</sup> T cell epitope peptide vaccines is dependent upon CD40LDiana Llopiz, Eduardo Huarte, Marta Ruiz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2007
Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 proteinAintzane Zabaleta, Diana Llopiz, Laura Arribillaga, et al.
Cancers|July 2, 2021
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationNoelia Casares, Laura Arribillaga, Pablo Sarobe, et al.
Journal of Virology|April 23, 2002
Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteinsPablo Sarobe, Juan José Lasarte, Noelia Casares, et al.
Cytokine|December 28, 2010
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisLaura Arribillaga, Javier Dotor, María Basagoiti, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Pageof 9